Kaya, Ö. Et Al. 2023. Long-Term Omalizumab Therapy in Patients with Chronic Spontaneous Urticaria: Does it Increase the Risk of COVID-19?. Dermatology practical & conceptual , vol.13, no.3 .

Kaya, Ö., Keskinkaya, Z., Işık Mermutlu, S., Oğuz Kılıç, S., & Öztürk, S., (2023). Long-Term Omalizumab Therapy in Patients with Chronic Spontaneous Urticaria: Does it Increase the Risk of COVID-19?. Dermatology practical & conceptual , vol.13, no.3.

Kaya, ÖZGE Et Al. "Long-Term Omalizumab Therapy in Patients with Chronic Spontaneous Urticaria: Does it Increase the Risk of COVID-19?," Dermatology practical & conceptual , vol.13, no.3, 2023

Kaya, ÖZGE Et Al. "Long-Term Omalizumab Therapy in Patients with Chronic Spontaneous Urticaria: Does it Increase the Risk of COVID-19?." Dermatology practical & conceptual , vol.13, no.3, 2023

Kaya, Ö. Et Al. (2023) . "Long-Term Omalizumab Therapy in Patients with Chronic Spontaneous Urticaria: Does it Increase the Risk of COVID-19?." Dermatology practical & conceptual , vol.13, no.3.

@article{article, author={ÖZGE KAYA Et Al. }, title={Long-Term Omalizumab Therapy in Patients with Chronic Spontaneous Urticaria: Does it Increase the Risk of COVID-19?}, journal={Dermatology practical & conceptual}, year=2023}